Â鶹ѧÉú¾«Æ·°æ

The interdisciplinary research hub connects experts in diabetes, heart disease, kidney disease, and more to uncover the metabolic roots of human health.

A new study shows a sharp rise in rates of cognitive disability within the U.S. over the past decade, especially for adults under the age of 40.

The new research will leverage nearly 40,000 blood samples to learn how blood pressure control could change the course of aging.

A new survey of people enrolled in Utah’s medical cannabis program reveals why some people turn to unregulated cannabis to treat their medical conditions, providing a first step toward reducing...

James M. Hotaling, MD, has been named the inaugural Chief Innovation Officer for Â鶹ѧÉú¾«Æ·°æ, effective September 1, 2025.

For the 16th consecutive year, Â鶹ѧÉú¾«Æ·°æ has been recognized as a top performer in the 2025 Bernard A. Birnbaum, MD, Quality Leadership Ranking by Vizient, Inc.

Baxdrostat reduces the levels of a hormone that drives high blood pressure and could transform hypertension care.

Kathy Wilets, MPA, has been named System Chief Communications Officer and Joe Borgenicht has been named System Chief Marketing Officer for Â鶹ѧÉú¾«Æ·°æ.

A new research study reveals when food insecurity spikes for new Utah residents.

Â鶹ѧÉú¾«Æ·°æ has launched a dedicated clinic for patients with polycystic kidney disease (PKD), offering specialized care, genetic counseling, and support services to improve outcomes and quality of...

Charles (Chuck) Ray, MD, PhD, has been named Interim Chair of the Department of Radiology and Imaging Sciences in the Spencer Fox Eccles School of Medicine at the University of...

Â鶹ѧÉú¾«Æ·°æ earned silver recognition in 2025 from the AMA’s Joy in Medicine® program for its efforts to reduce physician burnout and support clinician well-being.